Clearside Biomedical
CLSD
CLSD
54 hedge funds and large institutions have $9.62M invested in Clearside Biomedical in 2023 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.2% less ownership
Funds ownership: 13.98% → 13.79% (-0.2%)
15% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 13
Holders
54
Holding in Top 10
–
Calls
$136K
Puts
$117K
Top Buyers
| 1 | +$136K | |
| 2 | +$123K | |
| 3 | +$53.6K | |
| 4 |
VF
Virtu Financial
New York
|
+$38K |
| 5 |
Millennium Management
New York
|
+$37.3K |
Top Sellers
| 1 | -$137K | |
| 2 | -$112K | |
| 3 | -$104K | |
| 4 |
LNC
Lincoln National Corp
Radnor,
Pennsylvania
|
-$96K |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$89.4K |